Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAMRAD: Tamoxifen plus Everolimus in AI-Resistant Metastatic Breast Cancer
NCT01298713Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Mar 2008
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by ARCAGY. Started Mar 2008; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01298713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01298713.